Glycosidases are the enzymes involved in various biochemical processes related to metabolic disorders and diseases. Therefore, much effort has been focused on searching novel pharmacotherapy for the treatment of these ailments from medicinal plants due to higher safety margins. To pursue these efforts, the present study was performed to evaluate the -glucosidase inhibitory activities of thirty Korean medicinal plant extracts. Among the plants studied, Euonymus sachalinensis, Rhododendron schlippenbachii, Astilbe chinensis and Juglans regia d showed the strongest -glucosidase inhibitory activity with IC 50 Meliosma oldhamii and Symplocos chinensis showed moderate -glucosidase inhibition with IC 50 might prove to be a potential natural source for the treatment of metabolic ailments such as, diabetes, and need further investigations.
Introduction
Glycosidases are widespread in microorganisms, plants, and animals. They are a very important class of enzymes, which catalyze a hydrolytic cleavage of glycosidic bonds in oligosaccharides or glycoconjugates. Among these glycosidases, -glucosidase is able to catalyze the cleavage of glycosidic bonds involving terminal glucose connected at the site of cleavage through -linkage at the anomeric center (1-3).
Glycosidases are involved in several important biological processes (like: digestion, biosynthesis of glycoproteins and lysosomal catabolism of glucoconjugates) related to metabolic disorders and diseases, such as, diabetes, obesity, glycosphingolipid lysosomal storage disease, HIV infections, and tumors (1-3). These observations indicate that the inhibition of glycosidases would represent a novel pharmacological approach towards the treatment of the above mentioned complications, including diabetes.
Diabetes mellitus (DM) is a metabolic disorder characterized by chronic hyperglycemia quality of life and life expectancy of patients, as well as health care system (1, 4). In clinical practice, the DM treatment is restricted to the use of oral hypoglycemic agents and insulin, where the former possesses serious side effects (5). Therefore, many traditional herbal remedies for treating diabetes used throughout the world as plant drugs and herbal formulations, are frequently considered to be free from side effects and less toxic than the synthetic one (6). 
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-glucosidase inhibitory activities of these thirty plant extracts.
Experimental

Plant material
The dried and matured plant parts of thirty Korean medicinal herbs were obtained from Biotech company in Korea. A collection of voucher specimen is available with the company (Korea Collection of Herbal Extracts, 2000).
Extraction
The dried plant parts individually were chopped into small pieces and pulverized into a g, dry weight) were kept for extensive decoction in 80% methanol for 3 days at room temperature. The extracts were then concentrated using rotary vacuum evaporator at 20-30 to obtain the dried crude extracts.
Reagents
-Glucosidase (from Saccharomyces cerevisiae type I) and 4-nitrophenyl -Dglucopyranoside were purchased from commercially available reagents and solvents were used as received.
The enzyme inhibition activity for -glucosidase was evaluated according to the method previously reported by Shibano et al. 
4-nitrophenyl -D-glucopyranoside
Statistical analyses
All assays were performed at least three times with triplicate samples. All results are expressed as mean ± SD. IC 50 values were only determined concentration curve, in which the concentration of sample required for 50% inhibition was determined and expressed as IC 50 value.
Results and Discussion
Plants have always been used as an exemplary source of drugs and many of the currently available drugs have been directly or indirectly derived from them (8). Many herbal extracts are being used in the preparation of advanced remedies for diabetes, in which -glucosidase inhibitors play an important role by controlling postprandial blood glucose levels by means of retarding uptake of dietary carbohydrates (9). Therefore, in search of such potent -glucosidase inhibitors from natural source, in the present study thirty Korean medicinal plant extracts have been evaluated for their -glucosidase inhibitory activity and compared with 1, 2, 3, 4, 6-penta-Ogalloyl---D-glucose as a positive control.
In this study, the -glucosidase inhibitory activity of the thirty plant extracts was evaluated Pharm. Bull. (1997) In addition, in the present screening, eight plant extracts showed medium activity, ranging from 25 to 49%, 13 plant extracts showed less than 25% inhibition, and 3 plant extracts did not exhibit -glucosidase inhibitory activity (Table 1) .
The -glucosidase inhibitory potential of the compared to PGG (Table 1) , since crude extracts contain non-active components along with the active ones. Therefore, the crude extracts of Euonymus sachalinensis, Rhododendron schlippenbachii, Astilbe chinensis, Juglans regia, Meliosma oldhamii and Symplocos chinensis seem to be relatively potent inhibitors, where the inhibitory activity could further be active components. Thus, introduction of such innovative herbal extracts for the treatment of diabetes and other related metabolic disorders, where the -glycosidase inhibition plays a key role, may prove fortune. However, further in-vivo biochemical rationale.
